| 标题 |
[求助补充材料]
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Shukui Qin; Minshan Chen; Ann‐Lii Cheng; Ahmed O. Kaseb; Masatoshi Kudo; et al 出版日期:2023-10-20 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)